Systemic Evaluation on the Pharmacokinetics of Platinum-Based Anticancer Drugs From Animal to Cell Level: Based on Total Platinum and Intact Drugs.

Front Pharmacol · 2019 · PMC6960190 · PMID 31969818

Europe PMC DOI

hedged sentences

—

closest p

—

boldest claim

The sentences

a decreasing trendno p-value reported

Figure 3B shows a first increasing trend of cellular oxaliplatin, but then a decreasing trend.

also in 47,180 other papers

highly significantno p-value reported

P < 0.05 was considered statistically significant, while P < 0.01 was considered highly significant.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.